|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.16 CNY | -1.39% |
|
-2.07% | +7.33% |
| Apr. 25 | Sunshine Guojian Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 21 | Sunshine Guojian Pharmaceutical's Profit Surges Sixfold in 2023 | MT |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 730.6 million compared to CNY 527.35 million a year ago. Net income was CNY 163.92 million compared to CNY 1.18 million a year ago.
Basic earnings per share from continuing operations was CNY 0.27. Diluted earnings per share from continuing operations was CNY 0.27.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.33% | 2.09B | |
| -1.26% | 89.46B | |
| +2.76% | 40.74B | |
| -9.06% | 33.03B | |
| +55.32% | 24.68B | |
| -16.61% | 15.12B | |
| -9.14% | 12.81B | |
| -12.11% | 11.79B | |
| -43.61% | 11.64B | |
| +7.79% | 8.9B |
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD 
